 |
Justin Petrone is the editor of GenomeWeb's BioArray News and covers the microarray and biochip sector of the genomics market. E-mail Justin Petrone or follow his GenomeWeb Twitter account at @BioArrayNews. |
AmberGen Secures $600K to Develop Allergy Test on Illumina's BeadXpress Platform
May 15, 2012
AmberGen Secures $600K to Develop Allergy Test on Illumina's BeadXpress Platform
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- BGI Aims to Expand Proteomics Services, Purchase 50-Plus New Mass Spectrometers
June 17, 2011 / ProteoMonitor - Class Action Lawsuit Seeks to Stop Thermo Fisher's $13.6B Buy of Life Tech
April 23, 2013 / GenomeWeb Daily News - CGC Genetics Rolls out BeadXpress-based Test for Skeletal Dysplasia
July 17, 2012 / BioArray News - Thermo Fisher Acquires Rights to Preeclampsia Biomarker from Nephromics
May 17, 2012 / ProteoMonitor - Big Names Join Clinical Proteomics Push in 2011, Offering Ray of Optimism Amidst Difficult Year
January 6, 2012 / ProteoMonitor